514 related articles for article (PubMed ID: 34706401)
1. Methotrexate related cutaneous adverse drug reactions: a systematic literature review.
Zuber M; Harikrishna ; Vidhyashree ; Chhabra M; Venkataraman R; Kumar S; Rashid M
J Basic Clin Physiol Pharmacol; 2022 Sep; 33(5):549-565. PubMed ID: 34706401
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam and cutaneous adverse reactions: A systematic review of descriptive studies.
Rashid M; Rajan AK; Chhabra M; Kashyap A
Seizure; 2020 Feb; 75():101-109. PubMed ID: 31931437
[TBL] [Abstract][Full Text] [Related]
3. Metronidazole Induced Cutaneous Adverse Drug Reaction- A Systematic Review of Descriptive Studies.
Taj S; Zuber M; Hanumanthaiah VB; Venkataraman R; Puttegowda SK; Afrid S; Kiran S
Curr Rev Clin Exp Pharmacol; 2024; 19(3):269-284. PubMed ID: 37264661
[TBL] [Abstract][Full Text] [Related]
4. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
[TBL] [Abstract][Full Text] [Related]
5. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
6. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
Boyce EG; Halilovic J; Stan-Ugbene O
Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
[TBL] [Abstract][Full Text] [Related]
7. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Colebatch AN; Marks JL; Edwards CJ
Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate for ankylosing spondylitis.
Chen J; Liu C
Cochrane Database Syst Rev; 2004; (3):CD004524. PubMed ID: 15266537
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
Berna R; Rosenbach M; Margolis DJ; Mitra N; Baumrin E
Am J Clin Dermatol; 2022 Jul; 23(4):449-457. PubMed ID: 35486323
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
12. Atypical methotrexate dermatitis and vasculitis in a patient with ankylosing spondylitis.
Borman P; Bodur H; Güleç AT; Uçan H; Seçkin U; Mocan G
Rheumatol Int; 2000; 19(5):191-3. PubMed ID: 10984137
[TBL] [Abstract][Full Text] [Related]
13. [Use of methotrexate in spondylarthropathies. Review of the literature].
Toussirot E; Wendling D
Rev Med Interne; 1996; 17(4):333-9. PubMed ID: 8761799
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate for ankylosing spondylitis.
Chen J; Liu C; Lin J
Cochrane Database Syst Rev; 2006 Oct; (4):CD004524. PubMed ID: 17054209
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate for ankylosing spondylitis.
Chen J; Veras MM; Liu C; Lin J
Cochrane Database Syst Rev; 2013 Feb; (2):CD004524. PubMed ID: 23450553
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis.
Primka EJ; Camisa C
J Am Acad Dermatol; 1997 May; 36(5 Pt 2):815-8. PubMed ID: 9146556
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-induced epidermal necrosis: A case series of 24 patients.
Chen TJ; Chung WH; Chen CB; Hui RC; Huang YH; Lu YT; Wang CW; Wang KH; Yang LC; Hung SI
J Am Acad Dermatol; 2017 Aug; 77(2):247-255.e2. PubMed ID: 28499754
[TBL] [Abstract][Full Text] [Related]
18. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous ulceration as a sign of methotrexate toxicity.
Del Pozo J; Martínez W; García-Silva J; Almagro M; Peña-Penabad C; Fonseca E
Eur J Dermatol; 2001; 11(5):450-2. PubMed ID: 11525955
[TBL] [Abstract][Full Text] [Related]
20. Fatal low-dose methotrexate toxicity: A case report and literature review.
Ouellette S; Shah R; Razi S; Ashforth G; Wassef C
Dermatol Ther; 2022 Dec; 35(12):e15945. PubMed ID: 36259229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
